Last reviewed · How we verify
NasoShield
At a glance
| Generic name | NasoShield |
|---|---|
| Sponsor | Altimmune, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- NasoShield Study of Safety and Immunogenicity (PHASE1)
- NasoShield in Healthy Adults to Study Safety and Immunogenicity (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NasoShield CI brief — competitive landscape report
- NasoShield updates RSS · CI watch RSS
- Altimmune, Inc. portfolio CI